Five WVU researchers have received funding from the WVU Cancer Institute for their cancer-related pilot projects. Wei Du, MD, PhD, Sijin Wen, PhD, and Traci LeMasters, PhD, were each awarded an American Cancer Society-Institutional Research Grant. The individual grants were part of an American Cancer Society award to WVU in 2016 to support junior faculty members engaged in research at the Cancer Institute. Additionally, Mark Olfert, PhD, was awarded a grant from the Phillip R. Dino Innovative Research Fund and Paul Lockman, PhD, was awarded a grant from the Let the Journey Begin Fund.
Award recipients and their respective grants and projects:
Wei Du (School of Pharmacy Department of Pharmaceutical Sciences)
Targeting stem cell polarity in cell and gene therapy
Sijin Wen (School of Public Health Department of Biostatistics)
Bayesian Adaptive Design Evaluating Molecular Aberrations and Targeted Agents in Cancer Patients
Traci LeMasters (School of Pharmacy Department of Pharmaceutical Systems & Policy)
$26, 935 (ACS-IRG)
The Impact of Quality of Patient-Provider Communication on Smoking Cessation and Health Service Utilization among Older Survivors of Smoking Related Cancers
Mark Olfert (WVU School of Medicine Department of Human Performance-Exercise Physiology)
$25,000 (Phillip R. Dino Innovative Research Fund PPG)
Acute Vascular Effects of E-cigarette and Aerosolized Nicotine
Paul Lockman (School of Pharmacy Department of Pharmaceutical Sciences)
$50,000 (Let the Journey Begin Research Fund PPG)
Radiation effects on the blood-tumor barrier in brain metastases of lung cancer
W est Virginia University’s Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator. A native of upstate New York, the renowned gastrointestinal cancer expert came to Morgantown about two years ago. Goldberg previously worked at The Ohio State University’s Wexner Medical Center, where he served as the Klotz Family Professor of Cancer Research, the physician‐in‐ chief of the James Cancer Hospital, the associate director of the Ohio State Comprehensive Cancer Center and the acting division director of the Division of Medical Oncology. Before that, he also worked at the University of North Carolina and the Mayo Clinic. Goldberg is one of many world-class physicians recruited by WVU Medicine during the past few years, whose research has resulted in more than 300 peer-reviewed publications, including those in the New England Journal of Medicine, the Journal of the American Medical Association and the Journal of Clinical Oncology
The WVU Cancer Institute is among six organizations to receive an inaugural Medline Breast Cancer Awareness grant, which is awarded to organizations to further the mission to eradicate breast cancer and provide counseling. The grant drives awareness around prevention and early detection by providing support to organizations that provide direct patient care.
Researchers across campus are taking a One WVU approach to solving important problems and saving lives. At its core, an experimental therapeutics platform that integrates multiple disciplines from chemistry and biology to the health sciences and cancer institute.